Exhibit 99.2

Consent of Truist Securities, Inc.

The Board of Directors

Sanara MedTech Inc.

1200 Summit Avenue, Suite 414

Fort Worth, TX 76102

The Board of Directors:

We hereby consent to the inclusion of our opinion letter, dated July 28, 2026, to the Board of Directors of Sanara MedTech Inc. (“Sanara”) as Annex C to, and reference to such opinion letter under the headings “SUMMARY — Opinion of Sanara’s Financial Advisor” and “THE MERGER — Opinion of Sanara’s Financial Advisor” in, the proxy statement/prospectus relating to the proposed transaction involving Sanara and MiMedx Group, Inc. (“MiMedx”), which proxy statement/prospectus forms a part of the Registration Statement on Form S-4 of MiMedx (the “Registration Statement”). By giving such consent, we do not thereby admit that we are experts with respect to any part of such Registration Statement within the meaning of the term “expert” as used in, or that we come within the category of persons whose consent is required under, the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission promulgated thereunder.